The Health Economics Research Centre (HERC)
HERC was established by the University of Oxford in 1996. Our aim is to contribute to health and healthcare in the UK and internationally, by conducting research on economic aspects of health and disease, the costs and benefits of prevention and treatment, and the design and evaluation of health systems.
Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.
Dakin, H and Gray, AM, (2017), Statistics in Medicine
Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics.
Morrell L. et al, (2017), PharmacoEconomics
One-year costs of bilateral or single internal mammary grafts in the arterial revascularisation trial
Gray AM. et al, (2017), Heart
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1 year outcomes in the Arterial Revascularization Trial (ART)
Benedetto U. et al, (2017), European Journal of Cardio-Thoracic Surgery
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
Hamblin A. et al, (2017), PLoS Med, 14, e1002230 - e1002230
European Cardiovascular Disease Statistics 2017
Wilkins E et al, (2017), European Heart Network
Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
J, Leal et al, (2017), BMJ Open
Founded in 1996
Over 1000 course participants
4000+ followers on social media
Forthcoming HERC Seminar
Macroeconomic Conditions and Opioid Abuse
Professor Christopher J. Ruhm, Professor of Public Policy and Economics, Frank Batten School of Leadership and Public Policy, University of Virginia and NBER.
Friday 26th May 2017, 12pm